Earnings History Data for Calliditas Therapeutics (CALT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Calliditas Therapeutics
Calliditas Therapeutics AB is a specialty pharmaceutical company. It is focused on developing pharmaceutical products for patients with a significant unmet medical need. The compnay's lead candidate consist Nefecon. Calliditas Therapeutics AB is based in Stockholm, Sweden.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-08-2024 | PM | CALT | Calliditas Therapeutics | 1,167 | -0.16 | -0.25 | 0.00 | Calliditas Therapeutics GAAP EPS of -SEK 0.88, revenue of SEK 559.8M [8/13/2024 8:15 AM] |
39.23 | 0.05 (0.12%) |
0.0 | 0.0 (0.00%) |
15.25 - 41.90 | 5,919 | 10,000 | 0 | ||
| 23-05-2024 | PM | CALT | Calliditas Therapeutics | 640.00 | -0.88 | -0.14 | 0.00 | 22.75 | 1.04 (4.79%) |
23.27 | 1.56 (7.19%) |
15.25 - 29.30 | 7,917 | 0 | 3,056 | |||
|
|
||||||||||||||||||
| 21-02-2024 | PM | CALT | Calliditas Therapeutics AB | 632.66 | -0.06 | -0.09 | -0.01 | 21.05 | 0.13 (0.62%) |
20.20 | -0.72 (-3.44%) |
15.25 - 29.30 | 19,364 | 10,000 | 8,666 | |||
|
|
||||||||||||||||||
| 07-11-2023 | PM | CALT | Calliditas Therapeutics | 483.00 | -0.58 | -0.22 | 0.00 | 16.12 | -0.29 (-1.77%) |
15.86 | -0.55 (-3.35%) |
13.66 - 25.64 | 11,248 | 10,000 | 2,926 | |||
| 17-08-2023 | PM | CALT | Calliditas Therapeutics AB | 575.77 | -0.33 | -0.25 | -0.74 | Calliditas Therapeutics reports Q2 results [8/17/2023 12:50 PM] |
15.86 | -3.09 (-16.32%) |
16.50 | -2.45 (-12.93%) |
10.82 - 25.64 | 10,640 | 10,000 | 577 | ||
| 14-11-2022 | PM | 1:15 AM ET (Nov 14) |
CALT | Calliditas Therapeutics | 440.00 | -0.03 | -0.84 | 0.00 | Calliditas Therapeutics GAAP EPS of SEK 0.21, revenue of SEK 260.1M [11/14/2022 3:51 AM] |
15.53 | 0.28 (1.83%) |
0.0 | 0.0 (0.00%) |
10.82 - 27.50 | 5,462 | 10,000 | 0 | |
| 18-08-2022 | PM | CALT | Calliditas Therapeutics AB | 537.72 | -0.74 | -0.97 | -0.76 | Calliditas Therapeutics GAAP EPS of -SEK 3.62, revenue of SEK 64M [8/18/2022 1:36 AM] |
18.00 | -3.21 (-15.13%) |
17.63 | -3.58 (-16.88%) |
12.55 - 32.24 | 10,816 | 0 | 100 | ||
| 18-05-2022 | PM | CALT | Calliditas Therapeutics AB | 376.72 | -0.85 | -0.47 | -0.60 | Calliditas Therapeutics GAAP EPS of -SEK 3.95, revenue of SEK 49.7M [5/18/2022 1:49 AM] |
15.99 | 0.79 (5.20%) |
15.64 | 0.44 (2.89%) |
12.55 - 33.19 | 7,892 | 10,000 | 1,525 | ||
| 18-05-2021 | PM | 1:10 AM ET (May 18) |
CALT | Calliditas Therapeutics AB | 691.94 | -0.60 | -0.69 | -0.34 | Calliditas Therapeutics reports Q1 results [5/18/2021 9:32 AM] |
0.0 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.0 - 0.0 | 0 | 0 | 0 | |
| 18-02-2021 | PM | CALT | Calliditas Therapeutics Ab Sponsored Adr | 771.00 | -0.79 | -0.65 | 0.00 | 3.18 | -0.13 (-3.93%) |
0.0 | 0.0 (0.00%) |
1.80 - 3.44 | 26,083 | 0 | 0 | |||
|
|
||||||||||||||||||
| 12-11-2020 | PM | CALT | Calliditas Therapeutics AB | 865.49 | -0.62 | -0.39 | -0.27 | Calliditas Therapeutics reports Q3 results [11/12/2020 2:21 AM] |
2.38 | -0.03 (-1.24%) |
0.0 | 0.0 (0.00%) |
1.80 - 3.14 | 58,951 | 0 | 0 | ||
|
|
||||||||||||||||||
| 13-08-2020 | PM | CALT | Calliditas Therapeutics AB | 558.85 | -0.31 | -0.30 | 0.00 | 2.50 | -0.12 (-4.58%) |
0.0 | 0.0 (0.00%) |
1.80 - 3.14 | 35,193 | 0 | 0 | |||
|
|
||||||||||||||||||